Eli Lilly (LLY) PT Raised to $250 at Mizuho Securities as Donanemab Granted Breakthrough Therapy Designation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1428.61 +19.23 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1409.38 | 52 Week High | $88.16 | |||
| Open | $1440.00 | 52 Week Low | $67.88 | |||
| Day High | $1445.96 | P/E | 330.70 | |||
| Day Low | $1418.26 | EPS | $4.32 | |||
| Volume | 381,892 | |||||
